Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Alpha Fetoprotein L1 Measurement

Known as: AFPL1, Alpha Fetoprotein L1 
The determination of the amount of alpha fetoprotein L1 present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
Despite the increased risks of cancers and cardiovascular related diseases, tobacco smoking continues to be prevalent in the… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
2016
2016
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
Tobacco smoking is recognized as a global pandemic resulting in 6 million deaths per year. Despite a variety of anti-smoking… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.
The response to infection against Salmonella involves both B and T cell mediated immunity. An effective immunization can activate… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
2010
2010
Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.
The purpose of this study was to investigate the potential of intranasal (IN) immunization with Neisseria meningitides B… Expand
2009
2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
Most pathogens either invade the body or establish infection in mucosal tissues and represent an enormous challenge for vaccine… Expand
2009
2009
Intranasal immunization with AFCo1 induce systemic, mucosal and memory immune response in neonatal mice
Neonates have a poorly developed immune system. Respiratory pathogens cause disease during early periods of live. Consequently… Expand
  • figure 1
  • figure 2
2009
2009
C-3 : STUDY OF NEISSERIA MENINGITIDIS OMV USING PROTEOMIC TECHNIQUES
VacciMonitor 2009; Vol. 18 No. 2 Background and Aims. Meningococcal B strains accounts for some 72% and 28% of meningococcal… Expand
2009
2009
Mucosal immune response induced by proteoliposome and cochleate derived from serogroups B N. meningitidis
Mucosal vaccination offers attractive advantages to conventional systemic vaccination. Most pathogens enter or establish… Expand
  • table 1
  • figure 1
2007
2007
New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1
Neisseria meningitidis B proteoliposome (AFPL1 when used as adjuvant) and its derivative‐Cochleate (AFCo1) contain… Expand
2006
2006
NATURAL Neissera DERIVE PROTEOLIPOSOME AND COCHLEATE AS POTENT VACCINE ADJUVANTS
Summary Proteoliposome (AFPL1) and its derivated - Cochleate (AFCo1) contain immunopotentiating and immunomodulatory properties… Expand
  • figure 2
  • figure 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE